The plasminogen activator/plasmin system is essential for development of the joint inflammatory phase of collagen type II-induced arthritis
about
The Interplay Between Monocytes/Macrophages and CD4(+) T Cell Subsets in Rheumatoid ArthritisShear stress modulates macrophage-induced urokinase plasminogen activator expression in human chondrocytes.Urokinase-type plasminogen activator and arthritis progression: role in systemic disease with immune complex involvementPlasmin deficiency leads to fibrin accumulation and a compromised inflammatory response in the mouse brainBeneficial and detrimental effects of plasmin(ogen) during infection and sepsis in mice.Urokinase-type plasminogen activator and arthritis progression: contrasting roles in systemic and monoarticular arthritis models.Plasminogen is a joint-specific positive or negative determinant of arthritis pathogenesis in micePlasminogen activation/plasmin in rheumatoid arthritis: matrix degradation and more.Identification of CM1 as a Pathogenic Factor in Inflammatory Diseases and Cancer.Effects of hyaluronan treatment on lipopolysaccharide-challenged fibroblast-like synovial cells.Survivin is an essential mediator of arthritis interacting with urokinase signalling.Fibrin(ogen) exacerbates inflammatory joint disease through a mechanism linked to the integrin alphaMbeta2 binding motif.Establishment and characterization of a sustained delayed-type hypersensitivity model with arthritic manifestations in C57BL/6J mice.Antibody-induced arthritis: disease mechanisms and genes involved at the effector phase of arthritis.Emerging roles of serine proteinases in tissue turnover in arthritis.L-type calcium channel blockers exert an antiinflammatory effect by suppressing expression of plasminogen receptors on macrophages.A suppressive effect of prostaglandin E2 on the expression of SERPINE1/plasminogen activator inhibitor-1 in human articular chondrocytes: An in vitro pilot study.Identification of a specific haptoglobin C-terminal fragment in arthritic synovial fluid and its effect on interleukin-6 expression.Regulation of plasminogen activator inhibitor 1 expression in human osteoarthritic chondrocytes by fluid shear stress: role of protein kinase Calpha.Monoclonal antibody production using a new supermacroporous cryogel bioreactor.Urokinase plasminogen activator gene deficiency inhibits fracture cartilage remodeling.A new function for old drugsFunctional autoantibodies against serpin E2 in rheumatoid arthritis.Antiplasmin, but not amiloride, prevents synovitis and cartilage damage following hemarthrosis in hemophilic mice.Protective effects of plasmin(ogen) in a mouse model of Staphylococcus aureus-induced arthritis.Urokinase plasminogen activator system in synovial fibroblasts from osteoarthritis patients: modulation by inflammatory mediators and neuropeptides.Reduction of in vitro invasion and in vivo cartilage degradation in a SCID mouse model by loss of function of the fibrinolytic system of rheumatoid arthritis synovial fibroblasts.
P2860
Q26774681-047B2790-FA10-4DA5-9E0D-6829E347D037Q33766376-4625FCA7-2E6D-4454-8573-0FAEFB8A527BQ33923258-7B8DD389-FC51-4FF5-B45D-46A3E654516EQ33997270-296EEB09-23CC-41D1-9AAC-CC0EB9548E27Q34024041-9C34D98C-3BF2-4F63-B856-1D98BB64DDAEQ34346433-78DCFFBE-9DDF-40CD-85A9-DAF60839ED8EQ34383596-D2290D66-6726-4572-8548-C9E093521FC2Q35083704-0802C820-A31D-4634-A551-637C27563FF9Q35157035-38C5C790-E370-4E34-AD59-0B5A6EFAA151Q35769032-8F15AE27-5F71-4C5D-8581-73F2A53CC696Q35893385-1D1BADC1-7F8E-4323-8986-D16EE6A304B5Q36025268-0E08D7EC-5719-416F-81C2-F455B5741DD4Q36246082-ED5A0DCA-939D-4A58-A360-692245CF9213Q36718541-937E0376-434A-4E5E-80CB-75B2BF408345Q37335332-9421F2C8-7D70-4B84-B9AA-A7602290F5E4Q37351367-C6D87DF5-F52D-4D8D-B8F3-CD5BCDE50B79Q37358095-35867BA1-B40F-4EF0-88A9-0E29B3B38B6BQ39148322-8B9B12D7-483B-408A-A41E-ECFBABFD9CF2Q39818594-CFF9F7BA-81DB-405D-8F19-69DD4D5254F6Q40115748-4C32F363-AB2E-4B24-93C2-31ABF57A7118Q42438871-B0A5231D-581B-4C07-B245-4A4EE5C0FDD1Q42861630-DE15C90B-33B1-43DF-A463-75F519A724D9Q43205819-87744D38-A3AA-4A14-B17D-8819962E855FQ45858482-A6F2DBF3-CED3-4312-A0BF-2DDB7DF3678BQ46724730-6B73EEDC-5EF8-4D2C-B16C-5B5FF17B5235Q48120538-407649CF-9583-4A68-B3E6-3FFCEAB0CB38Q54374381-6BCBD0F5-D969-47C3-B462-C546B913C5EF
P2860
The plasminogen activator/plasmin system is essential for development of the joint inflammatory phase of collagen type II-induced arthritis
description
2005 nî lūn-bûn
@nan
2005 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի մարտին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
The plasminogen activator/plas ...... agen type II-induced arthritis
@ast
The plasminogen activator/plas ...... agen type II-induced arthritis
@en
type
label
The plasminogen activator/plas ...... agen type II-induced arthritis
@ast
The plasminogen activator/plas ...... agen type II-induced arthritis
@en
prefLabel
The plasminogen activator/plas ...... agen type II-induced arthritis
@ast
The plasminogen activator/plas ...... agen type II-induced arthritis
@en
P2093
P2860
P1476
The plasminogen activator/plas ...... agen type II-induced arthritis
@en
P2093
Annelii Ny
Göran Leonardsson
Rikard Holmdahl
P2860
P304
P356
10.1016/S0002-9440(10)62299-7
P407
P577
2005-03-01T00:00:00Z